Skip to content
Recall Observatory FDA recall evidence

Drug product

Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)

D-0541-2025

June 30, 2025

Class II

Product summary

Firm
Cipla USA, Inc.
Event
Event 97170
Status
Ongoing
Classification
Class II
Quantity
13,680 ampoules
Official record key
drug-enforcement:D-0541-2025

Official wording

Reason: Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

Code information: Batch # 4IA0505, Exp 09/31/2026

Distribution pattern: Distributed Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility